Literature DB >> 33437891

Similarities and differences between non-alcoholic fatty liver disease (NAFLD) & alcohol-associated liver disease (ALD).

Ashwani K Singal1.   

Abstract

Entities:  

Year:  2021        PMID： 33437891      PMCID： PMC7792989          DOI： 10.21037/tgh-2019-nafld-15

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  3 in total

1.  Trends in Liver Disease Etiology Among Adults Awaiting Liver Transplantation in the United States, 2014-2019.

Authors:  Robert J Wong; Ashwani K Singal
Journal:  JAMA Netw Open       Date:  2020-02-05

2.  NASH Is the Most Rapidly Growing Etiology for Acute-on-Chronic Liver Failure-Related Hospitalization and Disease Burden in the United States: A Population-Based Study.

Authors:  Page Axley; Zunirah Ahmed; Sumant Arora; Allen Haas; Yong-Fang Kuo; Patrick S Kamath; Ashwani K Singal
Journal:  Liver Transpl       Date:  2019-05       Impact factor: 5.799

3.  Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.

Authors:  Mohamed Shoreibah; Evan Raff; Joseph Bloomer; Donny Kakati; Khalid Rasheed; Yong-Fang Kuo; Ashwani K Singal
Journal:  Ann Hepatol       Date:  2016 Mar-Apr       Impact factor: 2.400
  3 in total
  3 in total

1.  Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction.

Authors:  Amedeo Lonardo; Ashwani K Singal; Natalia Osna; Kusum K Kharbanda
Journal:  Metab Target Organ Damage       Date:  2022-08-22

2.  Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter.

Authors:  Anca Trifan; Remus Stafie; Adrian Rotaru; Ermina Stratina; Sebastian Zenovia; Robert Nastasa; Laura Huiban; Tudor Cuciureanu; Cristina Muzica; Stefan Chiriac; Irina Girleanu; Ana-Maria Singeap; Catalin Sfarti; Camelia Cojocariu; Oana Petrea; Carol Stanciu
Journal:  J Clin Med       Date:  2022-10-09       Impact factor: 4.964

Review 3.  Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease.

Authors:  Yuanqiang Ma; Gyurim Lee; Su-Young Heo; Yoon-Seok Roh
Journal:  Antioxidants (Basel)       Date:  2021-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.